Infliximab-induced psoriasis in a patient with crohn's disease

Infliximab is a well-known treatment for inflammatory bowel diseases [IBDs] and psoriasis. Paradoxically, there have been numerous reports of new-onset psoriasis following tumor necrosis factor-??antagonist therapy in patients with IBD. Here, we report a case with Crohn's disease who developed Infliximab-induced plaque-type psoriasis 4 months after initiation of treatment with Infliximab